Simvastatine tablet
Formulation (FDF) · tablet · 10mg 20mg 40mg 80mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Simvastatine tablet
- Dosage Form
- tablet
- Strength
- 10mg 20mg 40mg 80mg
- Therapy Area
- Cardiovascular
- Indication
- Hypercholesterolaemia; Low density lipoprotein increased; Apolipoprotein B increased; Hypertriglyceridaemia; High density lipoprotein decreased; Cardiovascular event prevention
- Current Status
- Official FDF licensing catalog (UB728)
- GMP Certification
- US - FDA; UK - MHRA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price